Effects of Tyrosine Kinase Inhibitor-masitinib Mesylate on Canine Mammary Tumour Cell Lines

INTRODUCTION: Masitinib mesylate, a selective tyrosine kinase inhibitor of the c-KIT receptor, is used for the treatment of mast cell tumours in dogs. Masitinib has previously been investigated in various cancers; however, its potential anticancer effect in canine mammary tumours (CMTs) is unknown....

Descripción completa

Detalles Bibliográficos
Autores principales: Ustun-Alkan, Fulya, Bakırel, Tülay, Üstüner, Oya, Anlas, Ceren, Cinar, Suzan, Yıldırım, Funda, Gürel, Aydın
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643080/
https://www.ncbi.nlm.nih.gov/pubmed/34917849
http://dx.doi.org/10.2478/jvetres-2021-042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643080/
https://www.ncbi.nlm.nih.gov/pubmed/34917849
http://dx.doi.org/10.2478/jvetres-2021-042

Ejemplares similares